TGFB1 and neoplasm: Firstly, not all local treatments are beneficial for anti-tumor immunity, as they can induce hypoxia, increased vascular permeability, and the release of certain cytokines (such as VEGF and TGFβ) that inhibit the effectiveness of anti-tumor immune responses (17).